Neuropilin 1 binds PDGF-D and is a co-receptor in PDGF-D-PDGFRβ signaling

Journal of Cell Science

Volumn 130, Issue 8, 2017, Pages 1365-1378

  Muhl, Lars ^a   Folestad, Erika Bergsten ^a   Gladh, Hanna ^a   Wang, Yixin ^a   Moessinger, Christine ^a   Jakobsson, Lars ^a   Eriksson, Ulf ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Co receptor; Endothelial cells; NRP1; PDGF D; Pericyte; Trans signaling

Indexed keywords

ARGININE; NEUROPILIN 1; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR D; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2; LYMPHOKINE; PDGFD PROTEIN, HUMAN; PLATELET DERIVED GROWTH FACTOR; PROTEIN BINDING;

ANIMAL CELL; ARTICLE; CELL COMMUNICATION; CELL JUNCTION; COMPLEX FORMATION; CONTROLLED STUDY; ENDOTHELIUM CELL; EX VIVO STUDY; FIBROBLAST; HUMAN; HUMAN CELL; NONHUMAN; PERICYTE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; ANGIOGENESIS; ANIMAL; CARDIOVASCULAR DISEASE; METABOLISM; NEOPLASM; PIG; TRANSFORMED CELL LINE; VASCULAR ENDOTHELIUM;

ANIMALS; CARDIOVASCULAR DISEASES; CELL LINE, TRANSFORMED; ENDOTHELIUM, VASCULAR; FIBROBLASTS; HUMANS; INTERCELLULAR JUNCTIONS; LYMPHOKINES; NEOPLASMS; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROPILIN-1; PERICYTES; PLATELET-DERIVED GROWTH FACTOR; PROTEIN BINDING; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; SWINE;

EID: 85017570356     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.200493     Document Type: Article

References (48)

1. Andrae, J., Gallini, R. and Betsholtz, C. (2008). Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 22, 1276-1312.
2. Andrae, J., Ehrencrona, H., Gallini, R., Lal, M., Ding, H. and Betsholtz, C. (2013). Analysis of mice lacking the heparin-binding splice isoform of platelet-derived growth factor A. Mol. Cell. Biol. 33, 4030-4040.
3. Armulik, A., Genové, G. and Betsholtz, C. (2011). Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev. Cell 21, 193-215.
4. Aspalter, I. M., Gordon, E., Dubrac, A., Ragab, A., Narloch, J., Vizán, P., Geudens, I., Collins, R. T., Franco, C. A., Abrahams, C. L. et al. (2015). Alk1 and Alk5 inhibition by Nrp1 controls vascular sprouting downstream of Notch. Nat. Commun. 6, 7264.
5. Ball, S. G., Bayley, C., Shuttleworth, C. A. and Kielty, C. M. (2010). Neuropilin-1 regulates platelet-derived growth factor receptor signalling in mesenchymal stem cells. Biochem. J. 427, 29-40.
6. Ballmer-Hofer, K., Andersson, A. E., Ratcliffe, L. E. and Berger, P. (2011). Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output. Blood 118, 816-826.
7. Banerjee, S., Sengupta, K., Dhar, K., Mehta, S., D'amore, P. A., Dhar, G. and Banerjee, S. K. (2006). Breast cancer cells secreted platelet-derived growth factor-induced motility of vascular smooth muscle cells is mediated through neuropilin-1. Mol. Carcinog. 45, 871-880.
8. Bergsten, E., Uutela, M., Li, X., Pietras, K.,Östman, A., Heldin, C.-H., Alitalo, K. and Eriksson, U. (2001). PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor. Nat. Cell Biol. 3, 512-516.
9. Borkham-Kamphorst, E., Meurer, S. K., Van de Leur, E., Haas, U., Tihaa, L. and Weiskirchen, R. (2015). PDGF-D signaling in portal myofibroblasts and hepatic stellate cells proves identical to PDGF-B via both PDGF receptor type alpha and beta. Cell. Signal. 27, 1305-1314.
10. Cao, S., Yaqoob, U., Das, A., Shergill, U., Jagavelu, K., Huebert, R. C., Routray, C., Abdelmoneim, S., Vasdev, M., Leof, E. et al. (2010). Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF-beta signaling in hepatic stellate cells. J. Clin. Invest. 120, 2379-2394.
11. Cebe-Suarez, S., Grunewald, F. S., Jaussi, R., Li, X., Claesson-Welsh, L., Spillmann, D., Mercer, A. A., Prota, A. E. and Ballmer-Hofer, K. (2008). Orf virus VEGF-E NZ2 promotes paracellular NRP-1/VEGFR-2 coreceptor assembly via the peptide RPPR. FASEB J. 22, 3078-3086.
12. Cortez, E., Gladh, H., Braun, S., Bocci, M., Cordero, E., Björkström, N. K., Miyazaki, H., Michael, I. P., Eriksson, U., Folestad, E. et al. (2016). Functional malignant cell heterogeneity in pancreatic neuroendocrine tumors revealed by targeting of PDGF-DD. Proc. Natl. Acad. Sci. USA 113, E864-E873.
13. Delcombel, R., Janssen, L., Vassy, R., Gammons, M., Haddad, O., Richard, B., Letourneur, D., Bates, D., Hendricks, C., Waltenberger, J. et al. (2013). New prospects in the roles of the C-terminal domains of VEGF-A and their cooperation for ligand binding, cellular signaling and vessels formation. Angiogenesis 16, 353-371.
14. Ehnman, M., Li, H., Fredriksson, L., Pietras, K. and Eriksson, U. (2009). The uPA/uPAR system regulates the bioavailability of PDGF-DD: implications for tumour growth. Oncogene 28, 534-544.
15. Fantin, A., Herzog, B., Mahmoud, M., Yamaji, M., Plein, A., Denti, L., Ruhrberg, C. and Zachary, I. (2014). Neuropilin 1 (NRP1) hypomorphism combined with defective VEGF-A binding reveals novel roles for NRP1 in developmental and pathological angiogenesis. Development 141, 556-562.
16. Fredriksson, L., Li, H. and Eriksson, U. (2004). The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor. Rev. 15, 197-204.
17. Geevarghese, A. and Herman, I. M. (2014). Pericyte-endothelial crosstalk: implications and opportunities for advanced cellular therapies. Transl. Res. 163, 296-306.
18. Gelfand, M. V., Hagan, N., Tata, A., Oh, W.-J., Lacoste, B., Kang, K.-T., Kopycinska, J., Bischoff, J., Wang, J.-H. and Gu, C. (2014). Neuropilin-1 functions as a VEGFR2 co-receptor to guide developmental angiogenesis independent of ligand binding. Elife 3, e03720.
19. Gladh, H., Folestad, E. B., Muhl, L., Ehnman, M., Tannenberg, P., Lawrence, A.-L., Betsholtz, C. and Eriksson, U. (2016). Mice lacking platelet-derived growth factor d display a mild vascular phenotype. PLoS ONE 11, e0152276.
20. Gu, C., Limberg, B. J., Whitaker, G. B., Perman, B., Leahy, D. J., Rosenbaum, J. S., Ginty, D. D. and Kolodkin, A. L. (2002). Characterization of neuropilin-1 structural features that confer binding to semaphorin 3A and vascular endothelial growth factor 165. J. Biol. Chem. 277, 18069-18076.
21. Heldin, C. H. and Westermark, B. (1999). Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 79, 1283-1316.
22. Hellberg, C., Schmees, C., Karlsson, S., Ahgren, A. and Heldin, C.-H. (2009). Activation of protein kinase C alpha is necessary for sorting the PDGF betareceptor to Rab4a-dependent recycling. Mol. Biol. Cell 20, 2856-2863.
23. Hsu, J. and Smith, J. D. (2012). Genome-wide studies of gene expression relevant to coronary artery disease. Curr. Opin. Cardiol. 27, 210-213.
24. Huang,W. and Kim, H.-R. C. (2015). Dynamic regulation of platelet-derived growth factor D (PDGF-D) activity and extracellular spatial distribution by matriptasemediated proteolysis. J. Biol. Chem. 290, 9162-9170.
25. Karlsson, S., Kowanetz, K., Sandin, A., Persson, C., Ostman, A., Heldin, C.-H. and Hellberg, C. (2006). Loss of T-cell protein tyrosine phosphatase induces recycling of the platelet-derived growth factor (PDGF) beta-receptor but not the PDGF alpha-receptor. Mol. Biol. Cell 17, 4846-4855.
26. Koch, S. (2012). Neuropilin signalling in angiogenesis. Biochem. Soc. Trans. 40, 20-25.
27. Koch, S., van Meeteren, L. A., Morin, E., Testini, C.,Weström, S., Björkelund, H., Le Jan, S., Adler, J., Berger, P. and Claesson-Welsh, L. (2014). NRP1 presented in trans to the endothelium arrests VEGFR2 endocytosis, preventing angiogenic signaling and tumor initiation. Dev. Cell 28, 633-646.
28. Kofler, N. and Simons, M. (2016). The expanding role of neuropilin: regulation of transforming growth factor-beta and platelet-derived growth factor signaling in the vasculature. Curr. Opin Hematol. 23, 260-267.
29. Lanahan, A. A., Hermans, K., Claes, F., Kerley-Hamilton, J. S., Zhuang, Z. W., Giordano, F. J., Carmeliet, P. and Simons, M. (2010). VEGF receptor 2 endocytic trafficking regulates arterial morphogenesis. Dev. Cell 18, 713-724.
30. LaRochelle, W. J., Jeffers, M., McDonald, W. F., Chillakuru, R. A., Giese, N. A., Lokker, N. A., Sullivan, C., Boldog, F. L., Yang, M., Vernet, C. et al. (2001). PDGF-D, a new protease-activated growth factor. Nat. Cell Biol. 3, 517-521.
31. Li, X., Ponten, A., Aase, K., Karlsson, L., Abramsson, A., Uutela, M., Backstrom, G., Hellstrom, M., Bostrom, H., Li, H. et al. (2000). PDGF-C is a new proteaseactivated ligand for the PDGF alpha-receptor. Nat. Cell Biol. 2, 302-309.
32. Lindahl, P., Johansson, B. R., Leveen, P. and Betsholtz, C. (1997). Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277, 242-245.
33. Lindblom, P., Gerhardt, H., Liebner, S., Abramsson, A., Enge, M., Hellstrom, M., Backstrom, G., Fredriksson, S., Landegren, U., Nystrom, H. C. et al. (2003). Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev. 17, 1835-1840.
34. Mamluk, R., Gechtman, Z., Kutcher, M. E., Gasiunas, N., Gallagher, J. and Klagsbrun, M. (2002). Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain. J. Biol. Chem. 277, 24818-24825.
35. Parker, M. W., Xu, P., Li, X. and Vander Kooi, C. W. (2012). Structural basis for selective vascular endothelial growth factor-A (VEGF-A) binding to neuropilin-1. J. Biol. Chem. 287, 11082-11089.
36. Pellet-Many, C., Frankel, P., Jia, H. and Zachary, I. (2008). Neuropilins: structure, function and role in disease. Biochem. J. 411, 211-226.
37. Pellet-Many, C., Frankel, P., Evans, I. M., Herzog, B., Jünemann-Ramirez, M. and Zachary, I. C. (2011). Neuropilin-1 mediates PDGF stimulation of vascular smooth muscle cell migration and signalling via p130Cas. Biochem. J. 435, 609-618.
38. Pellet-Many, C., Mehta, V., Fields, L., Mahmoud, M., Lowe, V., Evans, I., Ruivo, J. and Zachary, I. (2015). Neuropilins 1 and 2 mediate neointimal hyperplasia and re-endothelialization following arterial injury. Cardiovasc. Res. 108, 288-298.
39. Plein, A., Fantin, A. and Ruhrberg, C. (2014). Neuropilin regulation of angiogenesis, arteriogenesis, and vascular permeability. Microcirculation 21, 315-323.
40. Ponten, A., Folestad, E. B., Pietras, K. and Eriksson, U. (2005). Platelet-derived growth factor D induces cardiac fibrosis and proliferation of vascular smooth muscle cells in heart-specific transgenic mice. Circ. Res. 97, 1036-1045.
41. Rhee, J. M., Pirity, M. K., Lackan, C. S., Long, J. Z., Kondoh, G., Takeda, J. and Hadjantonakis, A.-K. (2006). In vivo imaging and differential localization of lipidmodified GFP-variant fusions in embryonic stem cells and mice. Genesis 44, 202-218.
42. Roth, L., Prahst, C., Ruckdeschel, T., Savant, S.,Westrom, S., Fantin, A., Riedel, M., Heroult, M., Ruhrberg, C. and Augustin, H. G. (2016). Neuropilin-1 mediates vascular permeability independently of vascular endothelial growth factor receptor-2 activation. Sci. Signal. 9, ra42.
43. Shim, A. H.-R., Liu, H., Focia, P. J., Chen, X., Lin, P. C. and He, X. (2010). Structures of a platelet-derived growth factor/propeptide complex and a plateletderived growth factor/receptor complex. Proc. Natl. Acad. Sci. USA 107, 11307-11312.
44. Ustach, C. V. and Kim, H.-R. C. (2005). Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells. Mol. Cell. Biol. 25, 6279-6288.
45. Ustach, C. V., Huang, W., Conley-Lacomb, M. K., Lin, C.-Y., Che, M., Abrams, J. and Kim, H.-R. C. (2010). A novel signaling axis of matriptase/PDGF-D/ss-PDGFR in human prostate cancer. Cancer Res. 70, 9631-9640.
46. Wang, Z., Ahmad, A., Li, Y., Kong, D., Azmi, A. S., Banerjee, S. and Sarkar, F. H. (2010). Emerging roles of PDGF-D signaling pathway in tumor development and progression. Biochim. Biophys. Acta 1806, 122-130.
47. Zachary, I. (2014). Neuropilins: role in signalling, angiogenesis and disease. Chem. Immunol. Allergy 99, 37-70.
48. Zhu, X., Bergles, D. E. and Nishiyama, A. (2008). NG2 cells generate both oligodendrocytes and gray matter astrocytes. Development 135, 145-157.